Spironolactone for congestive heart failure.
Lindbloom
E J
EJ
LindbloomE@health.missouri.edu
Koenig
C J
CJ
D000284:Administration, Oral; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006177:Gynecomastia / Q000139:chemically induced; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000008:administration & dosage* / Q000009:adverse effects; D015996:Survival Rate
D000806:Angiotensin-Converting Enzyme Inhibitors; D013148:Spironolactone